Degradation of troponin I in serum or plasma: mechanisms, and analytical and clinical implications
Related Experiment Video
Updated: May 24, 2026
Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Giuseppe Lippi1, Gianfranco Cervellin
1U.O. Diagnostica Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Italy. glippi@ao.pr.it
Insights
Acute myocardial infarction (AMI) stems from prolonged myocardial ischemia. Cardiac troponins, crucial for AMI diagnosis, face detection challenges due to release mechanisms and protease degradation, particularly troponin I.
Area of Science:
- Cardiology
- Biochemistry
- Medical Diagnostics
Background:
- Acute myocardial infarction (AMI) is primarily caused by prolonged myocardial ischemia, leading to myocardiocyte injury and release of intracellular components.
- Cardiac troponins are established biomarkers for diagnosing AMI, reflecting plaque instability, rupture, ischemia, and necrosis.
- Assessing cardiac troponins in chest pain patients presents challenges due to complex release kinetics and enzymatic degradation.
Purpose of the Study:
- To discuss the challenges in diagnosing AMI using cardiac troponins.
- To focus on the mechanisms of troponin release and degradation affecting their detection.
- To highlight cardiac troponin I as a key biomarker and the role of immunoassays.
Main Methods:
- Review of mechanisms of cardiac troponin release from injured myocardium.
- Analysis of enzymatic degradation pathways affecting troponin immunoreactivity.
- Discussion of various immunoassays for cardiac troponin I measurement.
Main Results:
- Myocardial ischemia is the primary cause of AMI and myocardiocyte injury.
- Cardiac troponins are reliable but complex biomarkers for AMI diagnosis.
- Protease activity can alter troponin detection, impacting diagnostic accuracy.
Conclusions:
- Understanding troponin release and degradation is critical for accurate AMI diagnosis.
- Cardiac troponin I remains a vital biomarker, with immunoassays playing a key role in its measurement.
- Further research into troponin stability and detection methods is warranted.
Abstract:
A prolonged myocardial ischemia, which results from a total deprivation of blood supply to an area of cardiac muscle for an appreciable period of time, is the leading mechanism responsible for acute myocardial infarction (AMI). The irreversible injury of myocardiocytes and the subsequent release of a variety of intracellular components into blood is the cornerstone of the diagnosis of AMI. Cardiac troponins are advocated as the biochemical gold standards among the various biomarkers of plaque instability, plaque rupture, ischemia, reversible cellular injury, and early and late necrosis (i.e., irreversible injury). The assessment of cardiac troponins in the diagnostic approach of patients with chest pain presents, however, some specific challenges due to the complex mechanisms of release from the injured myocardium, as well as to the enzymatic degradation by cardiac and extracardiac proteases (i.e., calpains, caspases, cathepsin L, and gelatinase A) that might alter the immunoreactivity (and thus laboratory detection) of the molecules. These two aspects will be discussed in this article, with specific focus on cardiac troponin I, as a variety of immunoassays based on antibodies which recognize different epitopes on the molecule is available for the measurement of this important cardiac biomarker.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
01:30Acute Coronary Syndrome III: Diagnostic Studies
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:30Acute Coronary Syndrome I: Introduction